MEDDIC guide: qualify deals that actually close

MEDDIC came out of a concrete frustration. Reps at PTC in the mid-1990s were reporting heaps of "hot leads" that then evaporated — and pipeline meetings where leadership tried to guess which deals were real and which were wishful thinking. Dick Dunkel and Jack Napoli formulated MEDDIC as a checklist to separate the two. Result: PTC grew from $300M to $1B without adding a proportional number of reps.

Since then MEDDIC has become standard at a sweeping majority of SaaS companies in the enterprise segment. Between 2021 and 2022 MEDDPICC adoption doubled from 11% to 21% among B2B sales organizations. The win rate effect is well documented: 20–30% higher close rates compared to traditional qualification frameworks. Some reports show a 30–40% lift in the first year.

M – Metrics: what does the buyer gain in measurable terms?

Metrics is the first letter and the most often skipped. The question isn't "what do you need" but "what will it be worth in numbers if we solve it." Good answers are concrete: "we lose $80K per quarter on manual work your product would automate," not "we want to be more efficient." Without metrics you can't justify a price, you can't build the business case for the buyer, and you can't get an Economic Buyer to sign.

E – Economic Buyer: who actually holds the pen?

The Economic Buyer isn't the person who approves purchases. It's the person with authority to say yes or no when everyone else is uncertain. In complex deals it's often not the person you first speak to — and the rep's most important work is to climb to that level. A deal without documented contact with the Economic Buyer historically closes 50% less often. If you don't know who it is, the deal isn't qualified.

D – Decision Criteria: what's on the comparison list?

Decision Criteria are the exact criteria the buyer will compare you against. They often aren't the same as the ones listed in the RFP. The question is: "When you evaluate us against alternatives, which three things weigh most heavily?" If you don't know the answer, you'll lose to a competitor who does. Top reps influence Decision Criteria before they're finalized — that's where the deal is actually won.

D – Decision Process: what's the path from yes to signed?

Decision Process is the entire route: who needs to say yes, in what order, which meetings are required, which documents must be produced, how long each step takes. Teams with enforced MEDDIC scoring saw forecasting accuracy jump from 52% to 89%. The lift sits almost entirely in Decision Process — because if you know how it looks, you know when the deal actually closes.

I – Identify Pain: what hurts enough to act?

Identify Pain isn't a needs analysis. It's a quantification of what it costs the buyer to do nothing. Good reps ask: "If we do nothing about this, what happens in six months? In twelve?" If the answer is "nothing dramatic," the deal isn't mature yet and you should reroute energy to another opportunity. Pain is often the only thing that moves priorities inside a busy buyer team.

C – Champion: who sells for you when you're not in the room?

The Champion is the internal person on the buyer side who wins if your deal goes through — and is willing to fight for it when you're not there. That's the difference between a "contact" and a "champion": contacts give information, champions act for you. A deal without a champion rarely closes, no matter how good the other five letters look.

MEDDPICC: the extra letters P and C

MEDDPICC adds Paper Process (how the contract is actually drafted and approved) and Competition (who else you're up against, and why). Both are worth tracking on larger deals — Paper Process reveals the legal and procurement steps that often drag a deal out two extra quarters, and Competition forces you to articulate differentiation. For deals over $250K, MEDDPICC is usually worth the added complexity.

Three common MEDDIC mistakes

The first mistake: MEDDIC as a checklist after the deal has already been lost. It's a pipeline reporting tool, not a post-mortem. The second: not investing time to verify Metrics and Economic Buyer in early phase — then every deal is "qualified" on paper but none close. The third: using MEDDIC in the wrong segment. It's overkill for transactional sales under $25K.

Five steps to run MEDDIC in your pipeline next week

1. Add a MEDDIC tab in your CRM with a field per letter and require it filled for every active deal.
2. Set a rule: no deal moves to "Proposal" without documented Economic Buyer and quantified Metrics.
3. Use your next pipeline meeting to walk every deal missing a Champion — decide what's needed to develop one.
4. Create a Decision Process mapping template every rep fills in after discovery.
5. Measure forecasting accuracy before and after rollout. Expect 15–25 percentage point lift in the first quarter.

MEDDIC changes two things: how you see your own deals, and how your team talks about them. It makes pipeline meetings shorter and decisions better informed. If you want to practice discovery questions that drive out the answers MEDDIC demands — quantified metrics, identified Economic Buyers, documented pain — you can run the Salesprep pitch module against AI buyers playing different roles from CFO to end user. Three sessions a week is enough to start seeing MEDDIC field quality lift in CRM.